<DOC>
	<DOCNO>NCT02357303</DOCNO>
	<brief_summary>The upper endoscopy one common method diagnosis treatment upper gastrointestinal ( GI ) tract diseases provide unique opportunity identify early neoplastic lesion . Before upper endoscopy require 6 hour fast period [ 1 ] . However , even fast period , sometimes mucosal visualization , especially stomach , impaired presence foam , bubble gastric mucus . To improve visualization gastric mucosa , possible administrate oral solution defoaming agent Simethicone mucolytic agent like Pronase N-Acetylcysteine previously procedure . The aim project determine use premedication simethicone , alone association N-Acetylcysteine , improve mucosal visualization upper GI endoscopy .</brief_summary>
	<brief_title>Simethicone N-acetylcysteine Upper Endoscopy - Prospective Double-blinded Randomized Controlled Trial</brief_title>
	<detailed_description>. Study type : prospective , randomize , double-blinded , placebo-controlled trial : . Prospective inclusion patient ; ii . Randomization computer generate table ; iii . Allocation concealment seal , opaque envelope ; iv . Double-blinded - nurse instructed reveal treatment ; patient doctor unaware treatment ; b . Patient selection : consecutive series patient schedule upper gastrointestinal endoscopy ; Exclusion criterion - sedation , previous total gastrectomy , know neoplasia stenosis , allergies simethicone N-acetylcysteine , therapeutic urgent procedure ; c. Sample size : 270 ( 3 group 90 patient ) : improve `` excellent '' preparation 20 % ( value database ) 40 % assume normal distribution power 80 % ( Î±=0.05 ) , calculate sample size 3 group 82 ; allow 10 % dropout rate , sample size 90 ( 270 patient overall ) ; Groups : Group A - 100mL water ( placebo ) ; Group B - 100mL water plus 100mg Simethicone ; Group C - 100mL water plus 100mg Simethicone plus 600mg N-acetylcysteine ; d. Data collection method : form sheet fill nurse ( appendix 1 ) endoscopist ( appendix 2 ) ; e. Analysed variable : patient characteristic ( age , gender ) , indication endoscopy , time administration procedure , score mucosal visualization , side effect medication ; f. Statistical analysis : chi-square test .</detailed_description>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<mesh_term>Simethicone</mesh_term>
	<criteria>consecutive series patient schedule upper gastrointestinal endoscopy sign informed consent sedation previous total gastrectomy know neoplasia stenosis therapeutic urgent procedure allergies simethicone Nacetylcysteine</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Randomized control trial</keyword>
	<keyword>Endoscopy</keyword>
	<keyword>Gastric mucosa</keyword>
	<keyword>Simethicone</keyword>
	<keyword>Acetylcysteine</keyword>
</DOC>